Omacx Healthcare perturbed by 'vilification campaign'

Omacx Healthcare (Pvt) Limited, an importer and distributor of oncology (cancer) drugs, is concerned over a continuing smear campaign targeting the company on an alleged fraud, which was reported in September 2013.

At a time the due legal process into this alleged incident is going on, it is regrettable that people with vested interests - the notorious 'medical mafia' - is adding fuel to the fire to achieve its own sinister ends through an organized attempt to vilify Omacx Healthcare and tarnish its good name and image built over the years, a media release from the company said.

This is clearly evident from the adverse publicity still being generated in a section of the media on the alleged fraud pertaining to the oncology drug 'Oncaspar', at the Maharagama National Cancer Institute (NCI).

Certain unsuspecting media institutions are still being used to sling mud by describing Omacx as a 'blacklisted company'. News clippings are scanned and emailed to principals overseas in the hope, they would sever links with Omacx. These are despicable acts. Even though two years had lapsed since the alleged incident, the issue is being continuously whipped up to sling mud and keep the destructive flame alive to denigrate Omacx Healthcare.

It is an open secret that some competitors have also merrily joined the fray to push for the blacklisting of Omacx and effectively shut it out of the Health Ministry tender process for oncology drugs, the release said.